Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-20
2006-06-20
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S083000
Reexamination Certificate
active
07064131
ABSTRACT:
The present invention relates to a compound of formula (I) which are useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1.
REFERENCES:
patent: WO99/51228 (1999-10-01), None
patent: WO99/51236 (1999-10-01), None
patent: WO01/27116 (2001-04-01), None
Wermuth, C.G.,Molecular Variations Based on Isosteric Replacements, The Practise of Medicinal Chemistry, 1996, pp. 203-237.
Lander Peter Ambrose
Lohman Mark Christopher
Desai Rita
Eli Lilly and Company
Tucker Tina M.
LandOfFree
Compounds and methods for inhibiting MRP1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for inhibiting MRP1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for inhibiting MRP1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3708869